Arthroscopy Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Arthroscopy Pipeline Market Report Overview

Arthroscopy is a type of surgical procedure in which an orthopedic surgeon makes a small incision in the patient’s body and inserts a thin instrument called an arthroscope to visualize, diagnose, and treat the damages inside a joint.

The Arthroscopy pipeline market research report provides comprehensive information about the Arthroscopy pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Suture Anchors

·       Arthroscopy Implants

·       Arthroscopy Knee Implants

·       Arthroscopy Shoulder Implants

·       Arthroscopy Visualization Systems

·       Interference Screws

·       Arthroscopes

·       Arthroscopic Shavers

·       Arthroscopy Fluid Management Systems

·       Arthroscopy Hip Implants

Key Territories ·       The US

·       Europe

·       Australia

·       China

·       South Africa

·       South Korea

Key Regulatory Paths ·       510(k)

·       CE

·       TGA

·       NIFDS

·       NMPA

·       PMA

Leading Companies ·       3D Bio Corp

·       Anika Therapeutics Inc

·       Arthroscopic Innovations LLC

·       Cartimage Medical SAS

·       Clemson University

·       Cleveland Clinic Hospital

·       Elite Surgical Supplies (Pty) Ltd

·       Exactech Inc

·       Farmove Medical

·       Garland Surgical Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Arthroscopy Pipeline Market by Segments

The key segments in the Arthroscopy pipeline market are Suture Anchors, Arthroscopy Implants, Arthroscopy Knee Implants, Arthroscopy Shoulder Implants, Arthroscopy Visualization Systems, Interference Screws, Arthroscopes, Arthroscopic Shavers, Arthroscopy Fluid Management Systems, and Arthroscopy Hip Implants. As of August 2023, Suture Anchors have the highest number of pipeline products.

Arthroscopy Pipeline Market Analysis by Segments, 2023 (%)

Arthroscopy Pipeline Market Analysis by Segments, 2023 (%)

For more segment insights into the Arthroscopy pipeline market, download a free report sample

Arthroscopy Pipeline Market Segmentation by Territories

Some of the key territories in the Arthroscopy market are the US, Europe, Australia, China, South Africa, and South Korea. As of August 2023, the US has the highest number of pipeline products.

Arthroscopy Pipeline Market Analysis by Territories, 2023 (%)

Arthroscopy Pipeline Market Analysis by Territories, 2023 (%)

For more territory insights into the Arthroscopy pipeline market, download a free report sample

Arthroscopy Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Arthroscopy pipeline market are 510(k), CE, TGA, NIFDS, NMPA, and PMA. As of August 2023, 510(k) is the most followed pathway for pipeline products in the market.

Arthroscopy Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Arthroscopy Pipeline Market Analysis by Regulatory Paths, 2023 (%)

For more regulatory path insights into the Arthroscopy pipeline market, download a free report sample

Arthroscopy Pipeline Market – Competitive Landscape

Some of the key companies in the Arthroscopy pipeline market are 3D Bio Corp, Anika Therapeutics Inc, Arthroscopic Innovations LLC, Cartimage Medical SAS, Clemson University, Cleveland Clinic Hospital, Elite Surgical Supplies (Pty) Ltd, Exactech Inc, Farmove Medical, and Garland Surgical Ltd.

3D Bio Corp: The company operates as a biotechnology company that specializes in regenerative medicine and devices. It provides a bio-printing platform that focuses on whole-tissue living implants for near-term indications. 3D Bio is headquartered in New York, the US.

Anika Therapeutics Inc: The company develops, manufactures, and markets therapeutic products for degenerative orthopedic diseases and traumatic conditions. It offers solutions for ortho-biologics, dermal, ophthalmic, surgical, and veterinary applications. Anika has research and manufacturing facilities in Bedford, Massachusetts. The company offers its products through distributors in Latin America, Canada, Europe, the Middle East, and Asia. Anika is headquartered in Bedford, Massachusetts, the US.

Arthroscopy Pipeline Market Analysis by Companies, 2023

Arthroscopy Pipeline Market Analysis by Companies, 2023

For more company insights into the Arthroscopy pipeline market, download a free report sample

Segments Covered in the Report

Arthroscopy Pipeline Market Segments Outlook

  • Suture Anchors
  • Arthroscopy Implants
  • Arthroscopy Knee Implants
  • Arthroscopy Shoulder Implants
  • Arthroscopy Visualization Systems
  • Interference Screws
  • Arthroscopes
  • Arthroscopic Shavers
  • Arthroscopy Fluid Management Systems
  • Arthroscopy Hip Implants

Arthroscopy Pipeline Market Territories Outlook

  • The US
  • Europe
  • Australia
  • China
  • South Africa
  • South Korea

Arthroscopy Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • TGA
  • NIFDS
  • NMPA
  • PMA

Scope

This report provides:

  • Extensive coverage of the Arthroscopy under development.
  • Details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of Arthroscopy and lists of all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of Arthroscopy under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date


  • 1 Table of Contents

    • 1.1 List of Tables

    • 1.2 List of Figures



  • 2 Introduction

    • 2.1 Arthroscopy Overview



  • 3 Products under Development

    • 3.1 Arthroscopy - Pipeline Products by Stage of Development

    • 3.2 Arthroscopy - Pipeline Products by Segment

    • 3.3 Arthroscopy - Pipeline Products by Territory

    • 3.4 Arthroscopy - Pipeline Products by Regulatory Path

    • 3.5 Arthroscopy - Pipeline Products by Estimated Approval Date



  • 4 Arthroscopy - Pipeline Products under Development by Companies

    • 4.1 Arthroscopy Companies - Pipeline Products by Stage of Development

    • 4.2 Arthroscopy - Pipeline Products by Stage of Development



  • 5 Arthroscopy Companies and Product Overview

    • 5.1 3D Bio Corp Company Overview

      • 5.1.1 3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview



    • 5.2 Anika Therapeutics Inc Company Overview

      • 5.2.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview



    • 5.3 Arthroscopic Innovations LLC Company Overview

      • 5.3.1 Arthroscopic Innovations LLC Pipeline Products & Ongoing Clinical Trials Overview



    • 5.4 Cartimage Medical SAS Company Overview

      • 5.4.1 Cartimage Medical SAS Pipeline Products & Ongoing Clinical Trials Overview



    • 5.5 Clemson University Company Overview

      • 5.5.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview



    • 5.6 Cleveland Clinic Hospital Company Overview

      • 5.6.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview



    • 5.7 Elite Surgical Supplies (Pty) Ltd Company Overview

      • 5.7.1 Elite Surgical Supplies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview



    • 5.8 Exactech Inc Company Overview

      • 5.8.1 Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview



    • 5.9 Farmove Medical Company Overview

      • 5.9.1 Farmove Medical Pipeline Products & Ongoing Clinical Trials Overview



    • 5.10 Garland Surgical Ltd Company Overview

      • 5.10.1 Garland Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview



    • 5.11 Hospital for Special Surgery Company Overview

      • 5.11.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview



    • 5.12 KeriMedical SA Company Overview

      • 5.12.1 KeriMedical SA Pipeline Products & Ongoing Clinical Trials Overview



    • 5.13 Magnesium Development Company LLC Company Overview

      • 5.13.1 Magnesium Development Company LLC Pipeline Products & Ongoing Clinical Trials Overview



    • 5.14 NanoSurgery Technology Corp Company Overview

      • 5.14.1 NanoSurgery Technology Corp Pipeline Products & Ongoing Clinical Trials Overview



    • 5.15 Parcus Medical, LLC Company Overview

      • 5.15.1 Parcus Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview



    • 5.16 Path Keeper Surgical Company Overview

      • 5.16.1 Path Keeper Surgical Pipeline Products & Ongoing Clinical Trials Overview



    • 5.17 Pro-Dex Inc Company Overview

      • 5.17.1 Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview



    • 5.18 Rowan University Company Overview

      • 5.18.1 Rowan University Pipeline Products & Ongoing Clinical Trials Overview



    • 5.19 San Francisco VA Medical Center Company Overview

      • 5.19.1 San Francisco VA Medical Center Pipeline Products & Ongoing Clinical Trials Overview



    • 5.20 SINTX Technologies Inc Company Overview

      • 5.20.1 SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview



    • 5.21 Smith & Nephew Plc Company Overview

      • 5.21.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview



    • 5.22 SpineSmith Holdings LLC Company Overview

      • 5.22.1 SpineSmith Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview



    • 5.23 Temple University Company Overview

      • 5.23.1 Temple University Pipeline Products & Ongoing Clinical Trials Overview



    • 5.24 The Chaim Sheba Medical Center Company Overview

      • 5.24.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview



    • 5.25 Ti-TaMed (PTY) LTD. Company Overview

      • 5.25.1 Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview



    • 5.26 University of Alabama at Birmingham Company Overview

      • 5.26.1 University of Alabama at Birmingham Pipeline Products & Ongoing Clinical Trials Overview



    • 5.27 University of Florida Company Overview

      • 5.27.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview



    • 5.28 University of Missouri Company Overview

      • 5.28.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview



    • 5.29 University of Pittsburgh Company Overview

      • 5.29.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview



    • 5.30 University of Sydney Company Overview

      • 5.30.1 University of Sydney Pipeline Products & Ongoing Clinical Trials Overview



    • 5.31 University of Utah Company Overview

      • 5.31.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview



    • 5.32 Vericel Corp Company Overview

      • 5.32.1 Vericel Corp Pipeline Products & Ongoing Clinical Trials Overview





  • 6 Arthroscopy- Recent Developments

    • 6.1 Jul 14, 2023: Episurf Medical: Strategy Update to Take the Next Commercial Steps and Improve Financial Results

    • 6.2 Jun 27, 2023: NN Promotes Verlin Bush to Chief Commercial Officer

    • 6.3 May 18, 2023: Shanghai Kindly Medical Instruments Co. Announces Poll Results of Annual General Meeting & Payment of Final Dividend

    • 6.4 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023

    • 6.5 May 04, 2023: Episurf Medical announces summary from annual general meeting

    • 6.6 May 02, 2023: Zimmer Biomet Publishes 2022 Sustainability Report

    • 6.7 Apr 28, 2023: Episurf Announces Interim Report 1 January - 31 March 2023

    • 6.8 Apr 26, 2023: Smith & Nephew announces Q1 2023 trading update

    • 6.9 Apr 12, 2023: Medtronic has a layoff in California

    • 6.10 Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report

    • 6.11 Apr 04, 2023: Episurf Medical Announces 2022 Annual Report

    • 6.12 Mar 31, 2023: Episurf Medical AB (publ) Announces Notice of Annual General Meeting

    • 6.13 Mar 31, 2023: Bioventus announces Q4 and full-year 2022 financial results

    • 6.14 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders

    • 6.15 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company

    • 6.17 Mar 09, 2023: NN Reports Financial Results For Fourth Quarter and Full Year 2022

    • 6.18 Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022

    • 6.19 Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting

    • 6.20 Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results

    • 6.21 Feb 16, 2023: Lazurite Names Physicians to Medical Advisory Board

    • 6.22 Feb 07, 2023: Fortis Malar Hospitals Announces Standalone and Consolidated Financial Results for the Quarter and Nine Months Ended 31st December 2022

    • 6.23 Jan 24, 2023: IMPLANET Reports 2022 Annual Revenue of €8.0 Million, up 31%

    • 6.24 Jan 17, 2023: Precision Optics announces receipt of $2.3 million follow-on production order from large medical device company for otoscopy application

    • 6.25 Jan 16, 2023: Medisurge (division of Alliant Enterprises) and Signal Medical announce exclusive contract manufacturing strategic partnership

    • 6.26 Jan 04, 2023: Andreas Weller Named Tecomet President & Chief Executive Officer

    • 6.27 Nov 23, 2022: Medtronic Reports Quarterly Earnings

    • 6.28 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results

    • 6.29 Nov 21, 2022: Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance

    • 6.30 Nov 16, 2022: Episurf Interim Report 1 January - 30 September 2022

    • 6.31 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday

    • 6.32 Nov 07, 2022: Fortis Malar Hospitals Announces Unaudited Standalone and Consolidated Financial Results for the Quarter Ended September 30, 2022

    • 6.33 Oct 31, 2022: Ortoma presents breakthrough 3D concept for orthopedic surgery at AAHKS Annual Meeting in Dallas

    • 6.34 Sep 20, 2022: Implanet Publishes its 2022 Half-year Results

    • 6.35 Sep 14, 2022: Stryker launches pulse intelligent delivery platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting

    • 6.36 Sep 07, 2022: Medtronic to appear at September investor conferences

    • 6.37 Sep 06, 2022: Apyx Medical Corporation to Participate in the Lake Street Best Ideas Growth Conference

    • 6.38 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results

    • 6.39 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results



  • 7 Appendix

    • 7.1 Methodology

    • 7.2 About GlobalData

    • 7.3 Contact Us

    • 7.4 Disclaimer




Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 9

2 Introduction 10

2.1 Arthroscopy Overview 10

3 Products under Development 12

3.1 Arthroscopy – Pipeline Products by Stage of Development 12

3.2 Arthroscopy – Pipeline Products by Segment 13

3.3 Arthroscopy – Pipeline Products by Territory 14

3.4 Arthroscopy – Pipeline Products by Regulatory Path 15

3.5 Arthroscopy – Pipeline Products by Estimated Approval Date 16

4 Arthroscopy – Pipeline Products under Development by Companies 17

4.1 Arthroscopy Companies – Pipeline Products by Stage of Development 17

4.2 Arthroscopy – Pipeline Products by Stage of Development 19

5 Arthroscopy Companies and Product Overview 20

5.1 3D Bio Corp Company Overview 20

5.1.1 3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview 20

5.2 Anika Therapeutics Inc Company Overview 21

5.2.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.3 Arthroscopic Innovations LLC Company Overview 22

5.3.1 Arthroscopic Innovations LLC Pipeline Products & Ongoing Clinical Trials Overview 22

5.4 Cartimage Medical SAS Company Overview 23

5.4.1 Cartimage Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 23

5.5 Clemson University Company Overview 26

5.5.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 26

5.6 Cleveland Clinic Hospital Company Overview 27

5.6.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 Elite Surgical Supplies (Pty) Ltd Company Overview 28

5.7.1 Elite Surgical Supplies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

5.8 Exactech Inc Company Overview 29

5.8.1 Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.9 Farmove Medical Company Overview 30

5.9.1 Farmove Medical Pipeline Products & Ongoing Clinical Trials Overview 30

5.10 Garland Surgical Ltd Company Overview 31

5.10.1 Garland Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.11 Hospital for Special Surgery Company Overview 32

5.11.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 32

5.12 KeriMedical SA Company Overview 34

5.12.1 KeriMedical SA Pipeline Products & Ongoing Clinical Trials Overview 34

5.13 Magnesium Development Company LLC Company Overview 36

5.13.1 Magnesium Development Company LLC Pipeline Products & Ongoing Clinical Trials Overview 36

5.14 NanoSurgery Technology Corp Company Overview 37

5.14.1 NanoSurgery Technology Corp Pipeline Products & Ongoing Clinical Trials Overview 37

5.15 Parcus Medical, LLC Company Overview 38

5.15.1 Parcus Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 38

5.16 Path Keeper Surgical Company Overview 39

5.16.1 Path Keeper Surgical Pipeline Products & Ongoing Clinical Trials Overview 39

5.17 Pro-Dex Inc Company Overview 40

5.17.1 Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.18 Rowan University Company Overview 42

5.18.1 Rowan University Pipeline Products & Ongoing Clinical Trials Overview 42

5.19 San Francisco VA Medical Center Company Overview 43

5.19.1 San Francisco VA Medical Center Pipeline Products & Ongoing Clinical Trials Overview 43

5.20 SINTX Technologies Inc Company Overview 44

5.20.1 SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.21 Smith & Nephew Plc Company Overview 45

5.21.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 45

5.22 SpineSmith Holdings LLC Company Overview 46

5.22.1 SpineSmith Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 46

5.23 Temple University Company Overview 47

5.23.1 Temple University Pipeline Products & Ongoing Clinical Trials Overview 47

5.24 The Chaim Sheba Medical Center Company Overview 48

5.24.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 48

5.25 Ti-TaMed (PTY) LTD. Company Overview 49

5.25.1 Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview 49

5.26 University of Alabama at Birmingham Company Overview 50

5.26.1 University of Alabama at Birmingham Pipeline Products & Ongoing Clinical Trials Overview 50

5.27 University of Florida Company Overview 51

5.27.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 51

5.28 University of Missouri Company Overview 52

5.28.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 52

5.29 University of Pittsburgh Company Overview 53

5.29.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 53

5.30 University of Sydney Company Overview 54

5.30.1 University of Sydney Pipeline Products & Ongoing Clinical Trials Overview 54

5.31 University of Utah Company Overview 55

5.31.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 55

5.32 Vericel Corp Company Overview 56

5.32.1 Vericel Corp Pipeline Products & Ongoing Clinical Trials Overview 56

6 Arthroscopy- Recent Developments 58

6.1 Jul 14, 2023: Episurf Medical: Strategy Update to Take the Next Commercial Steps and Improve Financial Results 58

6.2 Jun 27, 2023: NN Promotes Verlin Bush to Chief Commercial Officer 59

6.3 May 18, 2023: Shanghai Kindly Medical Instruments Co. Announces Poll Results of Annual General Meeting & Payment of Final Dividend 59

6.4 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 61

6.5 May 04, 2023: Episurf Medical announces summary from annual general meeting 61

6.6 May 02, 2023: Zimmer Biomet Publishes 2022 Sustainability Report 62

6.7 Apr 28, 2023: Episurf Announces Interim Report 1 January – 31 March 2023 62

6.8 Apr 26, 2023: Smith & Nephew announces Q1 2023 trading update 63

6.9 Apr 12, 2023: Medtronic has a layoff in California 65

6.10 Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report 66

6.11 Apr 04, 2023: Episurf Medical Announces 2022 Annual Report 66

6.12 Mar 31, 2023: Episurf Medical AB (publ) Announces Notice of Annual General Meeting 67

6.13 Mar 31, 2023: Bioventus announces Q4 and full-year 2022 financial results 77

6.14 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders 79

6.15 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 80

6.16 Mar 09, 2023: Regenative Labs announces publication of groundbreaking paper on Wharton’s Jelly applications, opening the door for expanded treatment of the SI JOINT 80

6.17 Mar 09, 2023: NN Reports Financial Results For Fourth Quarter and Full Year 2022 80

6.18 Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022 83

6.19 Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting 83

6.20 Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results 83

6.21 Feb 16, 2023: Lazurite Names Physicians to Medical Advisory Board 85

6.22 Feb 07, 2023: Fortis Malar Hospitals Announces Standalone and Consolidated Financial Results for the Quarter and Nine Months Ended 31st December 2022 86

6.23 Jan 24, 2023: IMPLANET Reports 2022 Annual Revenue of €8.0 Million, up 31% 86

6.24 Jan 17, 2023: Precision Optics announces receipt of $2.3 million follow-on production order from large medical device company for otoscopy application 87

6.25 Jan 16, 2023: Medisurge (division of Alliant Enterprises) and Signal Medical announce exclusive contract manufacturing strategic partnership 87

6.26 Jan 04, 2023: Andreas Weller Named Tecomet President & Chief Executive Officer 88

6.27 Nov 23, 2022: Medtronic Reports Quarterly Earnings 88

6.28 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 88

6.29 Nov 21, 2022: Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance 94

6.30 Nov 16, 2022: Episurf Interim Report 1 January – 30 September 2022 96

6.31 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 97

6.32 Nov 07, 2022: Fortis Malar Hospitals Announces Unaudited Standalone and Consolidated Financial Results for the Quarter Ended September 30, 2022 97

6.33 Oct 31, 2022: Ortoma presents breakthrough 3D concept for orthopedic surgery at AAHKS Annual Meeting in Dallas 97

6.34 Sep 20, 2022: Implanet Publishes its 2022 Half-year Results 98

6.35 Sep 14, 2022: Stryker launches pulse intelligent delivery platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting 100

6.36 Sep 07, 2022: Medtronic to appear at September investor conferences 100

6.37 Sep 06, 2022: Apyx Medical Corporation to Participate in the Lake Street Best Ideas Growth Conference 101

6.38 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 101

6.39 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 103

7 Appendix 107

7.1 Methodology 107

7.2 About GlobalData 110

7.3 Contact Us 110

7.4 Disclaimer 110

Table

Arthroscopy – Pipeline Products by Stage of Development 12

Arthroscopy – Pipeline Products by Segment 13

Arthroscopy – Pipeline Products by Territory 14

Arthroscopy – Pipeline Products by Regulatory Path 15

Arthroscopy – Pipeline Products by Estimated Approval Date 16

Arthroscopy Companies – Pipeline Products by Stage of Development 17

Arthroscopy – Pipeline Products by Stage of Development 19

3D Bio Corp Pipeline Products & Ongoing Clinical Trials Overview 20

3D Printed Implant – Rotator Cuff Tear – Product Status 20

3D Printed Implant – Rotator Cuff Tear – Product Description 20

Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Interference Screw – Product Status 21

Interference Screw – Product Description 21

Arthroscopic Innovations LLC Pipeline Products & Ongoing Clinical Trials Overview 22

Intersector – Product Status 22

Intersector – Product Description 22

Cartimage Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 23

Arthroscopic Imaging Probe – Meniscal Repair – Product Status 23

Arthroscopic Imaging Probe – Meniscal Repair – Product Description 23

Arthroscopic Imaging Probe – Shoulder Arthroscopy – Product Status 24

Arthroscopic Imaging Probe – Shoulder Arthroscopy – Product Description 24

Arthroscopic Imaging Probe – Thoracoscopy – Product Status 24

Arthroscopic Imaging Probe – Thoracoscopy – Product Description 25

Clemson University Pipeline Products & Ongoing Clinical Trials Overview 26

Insita Pro – Product Status 26

Insita Pro – Product Description 26

Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 27

Elbow Implant – Product Status 27

Elbow Implant – Product Description 27

Elite Surgical Supplies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

Elite Arthroscopy Viewing Portal – Product Status 28

Elite Arthroscopy Viewing Portal – Product Description 28

Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Newton Balanced Knee System – Product Status 29

Newton Balanced Knee System – Product Description 29

Farmove Medical Pipeline Products & Ongoing Clinical Trials Overview 30

RefixSorb Absorbable Interference Screw – Product Status 30

RefixSorb Absorbable Interference Screw – Product Description 30

Garland Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

MaltaHip – Product Status 31

MaltaHip – Product Description 31

Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 32

Arthroscopic Surgery Tool – Product Status 32

Arthroscopic Surgery Tool – Product Description 32

Rotator Cuff Repair Patch – Product Status 33

Rotator Cuff Repair Patch – Product Description 33

KeriMedical SA Pipeline Products & Ongoing Clinical Trials Overview 34

KeriFix – Product Status 34

KeriFix – Product Description 34

KeriLock – Product Status 35

KeriLock – Product Description 35

Magnesium Development Company LLC Pipeline Products & Ongoing Clinical Trials Overview 36

Humeral Suture Anchor – Product Status 36

Humeral Suture Anchor – Product Description 36

NanoSurgery Technology Corp Pipeline Products & Ongoing Clinical Trials Overview 37

NanoScope – Product Status 37

NanoScope – Product Description 37

Parcus Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 38

Resorbable Suture Anchor – Product Status 38

Resorbable Suture Anchor – Product Description 38

Path Keeper Surgical Pipeline Products & Ongoing Clinical Trials Overview 39

spinal navigation system – Product Status 39

spinal navigation system – Product Description 39

Pro-Dex Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Arthroscopic Attachment – Product Status 40

Arthroscopic Attachment – Product Description 40

Arthroscopic Shaver – Product Status 41

Arthroscopic Shaver – Product Description 41

Rowan University Pipeline Products & Ongoing Clinical Trials Overview 42

Reference Implant – Product Status 42

Reference Implant – Product Description 42

San Francisco VA Medical Center Pipeline Products & Ongoing Clinical Trials Overview 43

Implantable Suture Anchor – Product Status 43

Implantable Suture Anchor – Product Description 43

SINTX Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Suture Anchor – Product Status 44

Suture Anchor – Product Description 44

Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 45

Platinum Handpiece – Product Status 45

Platinum Handpiece – Product Description 45

SpineSmith Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 46

Distraction Pin Aspiration Device – Product Status 46

Distraction Pin Aspiration Device – Product Description 46

Temple University Pipeline Products & Ongoing Clinical Trials Overview 47

Arthroscopic Probe Device – Product Status 47

Arthroscopic Probe Device – Product Description 47

The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 48

Temporomandibular Joint Arthroscopy Guide Device – Product Status 48

Temporomandibular Joint Arthroscopy Guide Device – Product Description 48

Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview 49

Arthroscopic Device – Product Status 49

Arthroscopic Device – Product Description 49

University of Alabama at Birmingham Pipeline Products & Ongoing Clinical Trials Overview 50

Hinged Microfracture Awl – Product Status 50

Hinged Microfracture Awl – Product Description 50

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 51

Shoulder Labral Anchor Delivery System – Product Status 51

Shoulder Labral Anchor Delivery System – Product Description 51

University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 52

Mizzou Knee Arthrometer Testing System (MKATS) – Product Status 52

Mizzou Knee Arthrometer Testing System (MKATS) – Product Description 52

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 53

Revised Hip Tether Device – Product Status 53

Revised Hip Tether Device – Product Description 53

University of Sydney Pipeline Products & Ongoing Clinical Trials Overview 54

Bone Implant – Product Status 54

Bone Implant – Product Description 54

University of Utah Pipeline Products & Ongoing Clinical Trials Overview 55

Distractor For Ankle and Subtalar Arthroscopy – Product Status 55

Distractor For Ankle and Subtalar Arthroscopy – Product Description 55

Vericel Corp Pipeline Products & Ongoing Clinical Trials Overview 56

MACI – Arthroscopic Delivery – Product Status 56

MACI – Arthroscopic Delivery – Product Description 57

Glossary 109

Figures

Arthroscopy – Pipeline Products by Stage of Development 12

Arthroscopy – Pipeline Products by Segment 13

Arthroscopy – Pipeline Products by Territory 14

Arthroscopy – Pipeline Products by Regulatory Path 15

Arthroscopy – Pipeline Products by Estimated Approval Date 16

Frequently asked questions

Arthroscopy Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Arthroscopy Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Arthroscopy Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Arthroscopy Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.